CS logo
small CS logo
Instituto de Cardiologia do Distrito Federal

Brasilia, DF, Brazil
Hospital in the Federal District
Estrada Parque Contorno do Bosque, S/N, Brasília - DF, 70658-700

About Instituto de Cardiologia do Distrito Federal


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Hospital do Coracao
2
Brasilia Heart Study Group
1
Hospital Israelita Albert Einstein
1
Hospital Sirio-Libanes
1
InCor Heart Institute
1
Instituto de Cardiologia de Santa Catarina
1
Pfizer
1
University of Manitoba
1
Total Rows: 9

Clinical Trials at Instituto de Cardiologia do Distrito Federal


During the past decade, Instituto de Cardiologia do Distrito Federal conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110033111122000000110000Started TrialsCompleted Trails20152016201720182019202001234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Simvastatin and Diastolic Dysfunction
2006-11-01
2009-08-01
Completed
55
GLORIA-AF Registry Program - Second and Third Phases
2011-11-07
2020-01-10
Completed
37,235
Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
2014-10-06
2022-07-31
Recruiting
1,100
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
2015-08-01
2019-01-01
Completed
3,799
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin
2017-07-06
2020-11-30
Unknown status
2,128

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto de Cardiologia do Distrito Federal" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Hospital do Coracao" with 2 trials sponsored, "Brasilia Heart Study Group" with 1 trials sponsored, "Hospital Israelita Albert Einstein" with 1 trials sponsored and "Hospital Sirio-Libanes" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Cardiologia do Distrito Federal" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Instituto de Cardiologia do Distrito Federal


According to Clinical.Site data, the most researched conditions in "Instituto de Cardiologia do Distrito Federal" are "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials) and "At Least 10 Points in Rassi Risk Score for Death" (1 trials). Many other conditions were trialed in "Instituto de Cardiologia do Distrito Federal" in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Cardiologia do Distrito Federal


Most popular intervention types in "Instituto de Cardiologia do Distrito Federal" are "Drug" (10 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Clopidogrel" (1 trials), "Dexamethasone" (1 trials) and "Double Dose Quadrivalent Influenza Vaccine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Cardiologia do Distrito Federal


The vast majority of trials in "Instituto de Cardiologia do Distrito Federal" are 12 trials for "All" genders.

Clinical Trials Status at Instituto de Cardiologia do Distrito Federal


Currently, there are NaN active trials in "Instituto de Cardiologia do Distrito Federal". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto de Cardiologia do Distrito Federal, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Cardiologia do Distrito Federal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status